These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28746263)

  • 21. Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial.
    Padayatchi N; Abdool Karim SS; Naidoo K; Grobler A; Friedland G
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):147-54. PubMed ID: 24429305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa.
    van der Walt M; Lancaster J; Shean K
    PLoS One; 2016; 11(3):e0144249. PubMed ID: 26950554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.
    Kigozi G; Heunis C; Chikobvu P; Botha S; van Rensburg D
    Int J Infect Dis; 2017 Jan; 54():95-102. PubMed ID: 27894985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial.
    Hesseling AC; Kim S; Madhi S; Nachman S; Schaaf HS; Violari A; Victor TC; McSherry G; Mitchell C; Cotton MF;
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):192-5. PubMed ID: 22236919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register.
    Schnippel K; Shearer K; Evans D; Berhanu R; Dlamini S; Ndjeka N
    Int J Infect Dis; 2015 Oct; 39():89-94. PubMed ID: 26358856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden of disease and risk factors for death among children treated for tuberculosis in Malawi.
    Flick RJ; Kim MH; Simon K; Munthali A; Hosseinipour MC; Rosenberg NE; Kazembe PN; Mpunga J; Ahmed S
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1046-54. PubMed ID: 27393538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
    Umanah TA; Ncayiyana JR; Nyasulu PS
    Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.
    Walls G; Bulifon S; Breysse S; Daneth T; Bonnet M; Hurtado N; Molfino L
    Glob Health Action; 2015; 8():25964. PubMed ID: 25623609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
    Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
    Satti H; McLaughlin MM; Omotayo DB; Keshavjee S; Becerra MC; Mukherjee JS; Seung KJ
    PLoS One; 2012; 7(5):e37114. PubMed ID: 22629356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho.
    Satti H; McLaughlin MM; Hedt-Gauthier B; Atwood SS; Omotayo DB; Ntlamelle L; Seung KJ
    PLoS One; 2012; 7(10):e46943. PubMed ID: 23115633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa.
    Schnippel K; Firnhaber C; Ndjeka N; Conradie F; Page-Shipp L; Berhanu R; Sinanovic E
    Int J Tuberc Lung Dis; 2017 Oct; 21(10):1106-1111. PubMed ID: 28911353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.
    Heysell SK; Ogarkov OB; Zhdanova S; Zorkaltseva E; Shugaeva S; Gratz J; Vitko S; Savilov ED; Koshcheyev ME; Houpt ER
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):187-92. PubMed ID: 26792470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa.
    Mokhele I; Jinga N; Berhanu R; Dlamini T; Long L; Evans D
    BMC Pregnancy Childbirth; 2021 Jun; 21(1):453. PubMed ID: 34182944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis.
    Azeez A; Ndege J; Mutambayi R
    Int J Mycobacteriol; 2018; 7(4):347-354. PubMed ID: 30531033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.
    Brust JC; Shah NS; Scott M; Chaiyachati K; Lygizos M; van der Merwe TL; Bamber S; Radebe Z; Loveday M; Moll AP; Margot B; Lalloo UG; Friedland GH; Gandhi NR
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):998-1004. PubMed ID: 22668560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
    Heller T; Lessells RJ; Wallrauch CG; Bärnighausen T; Cooke GS; Mhlongo L; Master I; Newell ML
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):420-6. PubMed ID: 20202299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    Atalell KA; Birhan Tebeje N; Ekubagewargies DT
    PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.